First FDA-Approved Hypersomnia Drug Data Published First FDA-Approved Hypersomnia Drug Data Published

Lower-sodium oxybate improves idiopathic hypersomnia symptoms and might be a useful first-line therapy or monotherapy or used in combination with alerting agents, newly published data show.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news